| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $665.8M | +8.7% |
| Cost of Revenue | $124.8M | +2.5% |
| Gross Profit | $541.0M | +10.2% |
| R&D Expense | $221.2M | +4.0% |
| SG&A Expense | $90.2M | +27.2% |
| Operating Income | $17.7M | +7177.8% |
| Interest Expense | $5.8M | -4.6% |
| Pre-tax Income | $32.6M | +158.6% |
| Income Tax | $18.5M | -14.3% |
| Net Income | $14.2M | +258.8% |
| EPS (Basic) | $0.17 | +254.5% |
| EPS (Diluted) | $0.16 | +245.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $561.9M | +20.2% |
| Accounts Receivable | $173.5M | -8.9% |
| Current Assets | $785.0M | +12.0% |
| Total Assets | $1.45B | +6.0% |
| Current Liabilities | $487.8M | +50.5% |
| Total Liabilities | $588.5M | -9.8% |
| Stockholders' Equity | $857.2M | +20.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $154.1M | +21.0% |
| Capital Expenditures | $14.1M | +38.2% |
| Investing Cash Flow | -$46.1M | -191.0% |
| Financing Cash Flow | -$7.0M | -118.6% |
| Free Cash Flow | $140.0M | +19.5% |